Control Bionics (ASX:CBL)

A Powerful Voice in Parliament: Emma Vulin MP and the NeuroNode Trilogy We are honoured to share the inspiring story of Emma Vulin, who lives with Motor Neurone Disease (MND) and recently used our NeuroNode Trilogy to deliver a speech in the Victorian Parliament. Emma’s courage and determination are a testament to the power of assistive technology in enabling meaningful communication. Seeing her speak in Parliament using our technology was a deeply moving moment for our team and a reminder of the impact these tools can have on real lives. Emma described the moment as historic, noting: “Today we made history by giving the first speech in the Victorian Parliament assisted by my new communication technology.” She also shared how this technology will support her in continuing to advocate for the issues that matter most to her community, even as MND progresses. We’d also like to extend our heartfelt thanks to Rebecca Staple, Emma’s dedicated speech pathologist, whose expertise and support played a vital role in helping Emma share her voice with the world. At Control Bionics, we are committed to creating life-changing connections for people living with complex communication and physical needs. Thank you Emma for showing us what’s possible when innovation meets purpose. #SpeechPathology #AAC #SpeechGeneratingDevice Better Rehab Aimee Donovan https://lnkd.in/gaFRzU57

Exciting days in Newcastle, Australia! Over the past two days, we had the opportunity to run sessions showcasing NeuroStrip, our latest innovation in surface EMG technology. NeuroStrip delivers real-time muscle activity feedback for diverse clinical applications – including advanced biofeedback for dysphagia management. What makes NeuroStrip even more remarkable? It weighs less than a sheet of paper and seamlessly conforms to the curvature of the submental region, ensuring comfort and ease of use during therapy. Seeing NeuroStrip in action is a big step forward in making therapy more engaging, measurable, and data-driven. A huge thank you to Ian, The Communication Clinic Speech Pathology Services and all the local speech pathologists and clients who participated in these fascinating sessions. #Dysphagia #SpeechPathology #AssistiveTechnology #NeuroStrip

Our CEO, Jeremy Steele, is proud to join a panel at BrainTech 2025 to explore how Control Bionics (ASX:CBL) is delivering real-world outcomes through patient- and carer-informed #Braintech. This summit brings together Australia’s leading researchers, innovators and changemakers across #NeuroTech, BCI, AI, and assistive innovation — and we’re excited to be part of the conversation. At Control Bionics, we’re building non-invasive, signal-driven technology that’s already improving lives across assistive communication, neuromuscular rehabilitation, and elite sport. 🔗 Learn more: braintechaustralia.com.au #AssistiveTech #Innovation #ControlBionics #DisabilityTech #BrainHealth Joe Durak

We're Heading To Closing The Gap 2025! https://lnkd.in/g7FXAZNp

🚀 Why non-invasive tech wins 👇 We were excited to see this recent Stockhead feature: “Control Bionics says outwitting the world’s richest man is a no-brainer.” The article draws a sharp contrast between invasive brain implants (e.g. Neuralink) and what we’ve been building at CBL: non-invasive, FDA-approved, wearable AAC + neuromuscular tech (like Neuronode and NeuroStrip). This is more than a grab for media attention. It’s a signal: the future of human–machine interfacing doesn’t have to break the skull. There's immense value, scale, and adoptability in what we do — and we’re just getting started. 🔗 Read the full article here: Biocurious: Control Bionics says outwitting the world’s richest man is a no-brainer https://lnkd.in/e7bm4mxv — 🙌 Grateful to the team, the users who drive us, and our partners who believe in a vision of assistive, non-invasive neural empowerment for all. #NeuroTech #AssistiveTech #Wearables #SportsScience #Rehabilitation #Innovation #ControlBionics

Thanks to Stockhead for highlighting Control Bionics (ASX:CBL) as one of the companies driving innovation in Australia’s booming care economy — now valued at over $327 billion, and projected to swell even further under supportive policy reforms. At Control Bionics, our EMG-based innovations—like NeuroNode, NeuroStrip, and DROVE—are helping individuals with severe disabilities communicate, move independently, and access rehabilitation with dignity. Read the full article to learn how we're putting real technology into practice, and what this growing national focus on care means for innovation, accessibility, and impact. https://lnkd.in/gg82_VAz #CareEconomy #MedTech #AssistiveTech #ASX #Neurotech Jeremy Steele Joe Durak Chris Titley

This week, in celebration of Speech Pathology Week, Speech Pathology Australia shared the story of Sienna – one of our incredible NeuroNode users. At just 14, Sienna recently said “mum” for the very first time using her communication device. A simple word, but one that carried years of effort, learning, and hope. Through the support of her family, speech pathologists, and her own determination, Sienna is now able to express her needs, share her feelings, participate in school, connect with friends and even set her sights on going to a Taylor Swift concert. Stories like Sienna’s remind us why we do what we do: to give people their voice, unlock independence, and create impact through communication. Watch the video here: https://lnkd.in/g-AjjaUP Jeremy Steele #technology #controlbionics #asx

Control Bionics at ALS Nexus 2025 Last week we joined the ALS community at ALS Nexus 2025 in Dallas Texas — an event uniting people living with ALS, caregivers, clinicians, researchers and innovators. At the conference we continued to champion our mission: to become the world’s leading provider of innovative augmentative communication and control devices for people with speech and movement disabilities — creating life changing connections and helping individuals maintain independence and control. Thank you to The The ALS Association for bringing together such an important gathering focused on progress and impact. #technology #global #controlbionics #asx

Great summary from Brayden Mifsud on how our NeuroStrip® technology is providing new insights to athletes and teams.